GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

PharmaResearch Co 214450.KQ · KRW

Health Care · KOSDAQ · 🇰🇷 South Korea

Compare

236,000

+0.64%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About PharmaResearch Co

Its shares trade on KOSDAQ under the ticker 214450.KQ. It has been listed since 24 July 2015. In the fiscal year to 31 December 2025, it reported revenue of ₩536.29bn and net income of ₩165.12bn. At that date it held total assets of ₩1.04trn and shareholders' equity of ₩689.33bn.

PharmaResearch Co., Ltd. engages in the research and development of refined raw materials for cell and tissue regeneration through marine bio technology. The company is headquartered in Gangneung, Gangwon-Do. The company went IPO on 2015-07-24. The firm produces and sells regenerated products such as pharmaceuticals, medical devices, and cosmetics. In addition, the Company is involved in the venture investment and real estate leasing. The firm mainly provides its products in domestic market.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Biotechnology
Listed since
24 Jul 2015

Leadership

Pay as last reported

  • Gi Seok KangCo-Chief Executive Officer, Director, since 2020
  • Shin Gyu KimCo-Chief Executive Officer, Director, since 2020
  • Yik Su KimVice President, Director
  • Si Yin KimDirector
  • Yong Seong KimNon-Executive Independent Director
  • Hyeon Jae LeeNon-Executive Independent Director
  • Jae Hwi LeeNon-Executive Independent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • PharmaResearch Co Ltd focuses on marine biotechnology for cell regeneration in Gangneung, KR.
  • The company's domestic market presence ensures stable revenue from pharmaceuticals and medical devices.
  • PharmaResearch's venture investments support growth in biotechnology and real estate sectors.

Weaknesses

  • PharmaResearch Co Ltd relies heavily on the domestic market for product sales in KR.
  • The company's IPO in 2015 limits access to international capital markets.
  • Limited product diversity beyond pharmaceuticals, medical devices, and cosmetics.

Opportunities

  • Expanding marine biotechnology applications in the Health Care sector globally.
  • Growing demand for regenerative medicine in the Asian market.
  • Increasing venture investment opportunities in Biotechnology and Real Estate.

Threats

  • Competition from established biotech firms in the Health Care industry.
  • Regulatory challenges in the Korean pharmaceutical market.
  • Economic downturns affecting domestic market demand for cosmetics.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.